Investment Criteria

Building Enduring Partnerships

Close-up 3D rendering of a DNA double helix in cool blue tones, with bead-like nucleotides spiraling into the distance.

Commercial‑stage Companies

1315 Capital is a healthcare private equity firm focused exclusively on growth stage companies. We invest in companies with proven business models and established product-market fit, partnering with management to build platforms of scale. Our platforms span founder- and family-owned businesses, institutionally backed companies, and corporate carve-outs. We aim to drive outsized growth through balance sheet capitalization and strategic value creation.

Microscope with micromanipulators and micro-pipettes performing IVF/ICSI on an oocyte in a petri dish, with a magnified embryo image on the monitor in the background.

Investment Criteria

What We Look For in Your Business:

Commercial-stage products and services with clear clinical or economic value

Evidence of product-market fit and durable customer adoption

Recurring or repeatable revenue models

Growth potential through new markets, channels, or customers

Alignment with our four healthcare verticals

Leadership teams seeking an engaged partner

Company & Deal Profile:

$15 to $50 million equity investments

Companies with potential to scale to $50 to $200 million in revenue

Strong margin potential with -$10 million to $10 million of EBITDA at time of investment

Flexibility for majority or minority ownership

Platforms with add-on M&A opportunities

Founder- or family-owned, institutionally backed companies, or corporate carve-outs

Deal Types:

Growth Equity

We understand that fast-growing companies consume working capital. Our investment proceeds help those companies with not just general working capital needs, but also expand sales and marketing, accelerate R&D, and support acquisitions.

Growth Buyouts

For profitable enterprises, we can provide liquidity across majority and minority deals for shareholders, founders, and management teams, while streamlining cap tables and board dynamics.

Corporate Carveouts

Our team understands the complexity of navigating corporate divestitures and has a track record of carving out deprioritized business units or product lines and pairing them with stellar management teams.

Have an opportunity that fits our focus? Contact us — we’d like to hear from you.